Patient controlled analgesia i.v. with morphine versus continuous epidural analgesia with bupivacaïne and sufentanil as pain relief after caesarean section.

Patient controlled analgesia i.v. with morphine versus continuous epidural analgesia with bupivacaïne and sufentanil as pain relief after caesarean section. - GAstudy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44865

Enrollment

Registered

2014-08-08

Start date

2015-01-20

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain relief after caesarean section

Interventions

Group A will get iv PCA with morphine 2mg/ml, bolus 2 mg, lock out period 5 minutes, with a maximum of 30 mg in 4 hours. Group B will get continuous epidural analgesia (CEA) with bupivacaine 0,125%

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ASA1 and ASA2 pregnant women scheduled for primary caesarean section

Exclusion criteria

Exclusion criteria: no informed consent pre-eclampsia coagulation disorders ASA 3 and more allergy for morphine, sufentanil or bupivacaine local infection on the site of injection of the epidural. increased intracranial pressure. uncorrected hypovolemia. relative contra-indications for epidural such as: neurological disorders like multiple sclerosis, malformation of the back, history of back operations, systemic infections.

Design outcomes

Primary

Measure	Time frame
Mobilization, how many hours after cesarean section does the patient stand beside the bed? VAS pain score post partum.	—

Secondary

Measure	Time frame
Time between caesarean section and stop PCA or CEA in hours. Time between caesarean section and discharge in hours. Use of oral pain relief. Side effects: nausea and vomitting, sedation score, pruritis.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)